Literature DB >> 27344221

A Classification Tool for Differentiation of Kawasaki Disease from Other Febrile Illnesses.

Shiying Hao1, Bo Jin1, Zhou Tan1, Zhen Li1, Jun Ji1, Guang Hu1, Yue Wang1, Xiaohong Deng1, John T Kanegaye2, Adriana H Tremoulet2, Jane C Burns2, Harvey J Cohen3, Xuefeng B Ling4.   

Abstract

OBJECTIVE: To develop and validate a novel decision tree-based clinical algorithm to differentiate Kawasaki disease (KD) from other pediatric febrile illnesses that share common clinical characteristics. STUDY
DESIGN: Using clinical and laboratory data from 801 subjects with acute KD (533 for development, and 268 for validation) and 479 febrile control subjects (318 for development, and 161 for validation), we developed a stepwise KD diagnostic algorithm combining our previously developed linear discriminant analysis (LDA)-based model with a newly developed tree-based algorithm.
RESULTS: The primary model (LDA) stratified the 1280 subjects into febrile controls (n = 276), indeterminate (n = 247), and KD (n = 757) subgroups. The subsequent model (decision trees) further classified the indeterminate group into febrile controls (n = 103) and KD (n = 58) subgroups, leaving only 29 of 801 KD (3.6%) and 57 of 479 febrile control (11.9%) subjects indeterminate. The 2-step algorithm had a sensitivity of 96.0% and a specificity of 78.5%, and correctly classified all subjects with KD who later developed coronary artery aneurysms.
CONCLUSION: The addition of a decision tree step increased sensitivity and specificity in the classification of subject with KD and febrile controls over our previously described LDA model. A multicenter trial is needed to prospectively determine its utility as a point of care diagnostic test for KD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-step algorithm; KD diagnosis; LDA; incomplete KD; random forest

Mesh:

Year:  2016        PMID: 27344221      PMCID: PMC5003696          DOI: 10.1016/j.jpeds.2016.05.060

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

1.  Missing value estimation methods for DNA microarrays.

Authors:  O Troyanskaya; M Cantor; G Sherlock; P Brown; T Hastie; R Tibshirani; D Botstein; R B Altman
Journal:  Bioinformatics       Date:  2001-06       Impact factor: 6.937

2.  Evolution of laboratory values in patients with Kawasaki disease.

Authors:  Adriana H Tremoulet; Sonia Jain; Divya Chandrasekar; Xiaoying Sun; Yuichiro Sato; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

3.  Point-of-care differentiation of Kawasaki disease from other febrile illnesses.

Authors:  Xuefeng B Ling; John T Kanegaye; Jun Ji; Sihua Peng; Yuichiro Sato; Adriana Tremoulet; Jane C Burns; Harvey J Cohen
Journal:  J Pediatr       Date:  2012-07-20       Impact factor: 4.406

4.  Complete and incomplete Kawasaki disease: two sides of the same coin.

Authors:  Cedric Manlhiot; Erin Christie; Brian W McCrindle; Hans Rosenberg; Nita Chahal; Rae S M Yeung
Journal:  Eur J Pediatr       Date:  2011-12-03       Impact factor: 3.183

5.  Human adenovirus infection in Kawasaki disease: a confounding bystander?

Authors:  Preeti Jaggi; Adriana E Kajon; Asuncion Mejias; Octavio Ramilo; Amy Leber
Journal:  Clin Infect Dis       Date:  2012-09-25       Impact factor: 9.079

6.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

7.  Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis.

Authors:  Kee-Soo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; YoungSook Hong; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2012-11-16       Impact factor: 3.183

8.  Incomplete Kawasaki disease with coronary artery involvement.

Authors:  A H Rowley; F Gonzalez-Crussi; S S Gidding; C E Duffy; S T Shulman
Journal:  J Pediatr       Date:  1987-03       Impact factor: 4.406

9.  Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.

Authors:  Elizabeth S Yellen; Kimberlee Gauvreau; Masato Takahashi; Jane C Burns; Stanford Shulman; Annette L Baker; Nancy Innocentini; Chiara Zambetti; Joan M Pancheri; Adam Ostrow; Jeffrey R Frazer; Robert P Sundel; David R Fulton; Jane W Newburger
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

10.  A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses.

Authors:  Xuefeng B Ling; Kenneth Lau; John T Kanegaye; Zheng Pan; Sihua Peng; Jun Ji; Gigi Liu; Yuichiro Sato; Tom T S Yu; John C Whitin; James Schilling; Jane C Burns; Harvey J Cohen
Journal:  BMC Med       Date:  2011-12-06       Impact factor: 8.775

  10 in total
  5 in total

1.  Comparison of Laboratory Data between Children with Kawasaki Disease and COVID-19.

Authors:  Xiao-Ping Liu; Ying-Hsien Huang; Yuh-Chyn Tsai; Shih-Feng Liu; Ho-Chang Kuo
Journal:  Children (Basel)       Date:  2022-04-28

2.  Pediatric Kawasaki Disease and Adult Human Immunodeficiency Virus Kawasaki-Like Syndrome Are Likely the Same Malady.

Authors:  Raymond M Johnson; Kelly R Bergmann; John J Manaloor; Xiaoqing Yu; James E Slaven; Anupam B Kharbanda
Journal:  Open Forum Infect Dis       Date:  2016-09-29       Impact factor: 3.835

Review 3.  Dissecting Kawasaki disease: a state-of-the-art review.

Authors:  S M Dietz; D van Stijn; D Burgner; M Levin; I M Kuipers; B A Hutten; T W Kuijpers
Journal:  Eur J Pediatr       Date:  2017-06-27       Impact factor: 3.183

4.  A novel score system of blood tests for differentiating Kawasaki disease from febrile children.

Authors:  Chih-Min Tsai; Chi-Hsiang Chu; Xi Liu; Ken-Pen Weng; Shih-Feng Liu; Ying-Hsien Huang; Ho-Chang Kuo
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

5.  Single center blind testing of a US multi-center validated diagnostic algorithm for Kawasaki disease in Taiwan.

Authors:  Ho-Chang Kuo; Shiying Hao; Bo Jin; C James Chou; Zhi Han; Ling-Sai Chang; Ying-Hsien Huang; Kuoyuan Hwa; John C Whitin; Karl G Sylvester; Charitha D Reddy; Henry Chubb; Scott R Ceresnak; John T Kanegaye; Adriana H Tremoulet; Jane C Burns; Doff McElhinney; Harvey J Cohen; Xuefeng B Ling
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.